MapLight Therapeutics, Inc. (MPLT) — Institutional Holders, Q2 2026 (page 2)

106 institutional investment managers reported a MPLT position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $941.0M. Every filer is listed below, ranked by position value, 100 per page; this page shows ranks 101 to 106. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.

MPLT 13F holders ranked 101–106 of 106

Institutional investors reporting a position in MapLight Therapeutics, Inc. on SEC Form 13F-HR for Q2 2026, ranked by reported value.
InstitutionValueQoQ
SJS Investment Consulting#101 · 18 sh$646.00New
EverSource Wealth Advisors#102 · 8 sh$287.00-81.8%
Allworth Financial#103 · 7 sh$251.00+16.7%
Integrated Wealth Concepts#104 · 7 sh$251.00New
Larson Financial Group#105 · 1 sh$36.00New
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM#106 · 144 sh—-86.4%

Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.